Latest News

In a recent assessment, the European Medicines Agency (EMA) investigated the impact of paternal exposure to Valproate, a medication used for epilepsy and bipolar disorder.…

The Gulf Health Council has launched an educational guide titled “Antimicrobial Resistance.” This guide addresses the significant health issue of antimicrobial resistance, aiming to raise…

The Dubai Health Authority (DHA) successfully concluded its summer training program for Emirati students. The program aimed to provide students with valuable practical experience and…

Abu Dhabi Global Healthcare Week is set to be held from May 13-15, 2024, at the Abu Dhabi National Exhibition Centre. Organized by the Department…

Exciting news in healthcare innovation! The FDA has granted clearance to the groundbreaking V-PRO maX 2 Low Temperature Sterilization System. This cutting-edge system is a…

In a proactive response to the increasing number of hospital admissions attributed to anaphylactic reactions, the Medicines and Healthcare products Regulatory Agency (MHRA) has reinforced…

Youth-led campaigns have been instrumental in finding fresh and innovative ways to communicate about public health issues. These campaigns have the ability to make complex…

The European Medicines Agency (EMA) has released a workshop report outlining recommendations to enhance clinical trials during public health emergencies in the EU. The report…

The Federal Institute for Drugs and Medical Devices (BfArM) has released important information regarding the pharmacovigilance of Voxzogo® (vosoritide). The latest update pertains to a…

The European Medicines Agency (EMA) has released a review highlighting the use of real-world evidence (RWE) in regulatory decision-making. Real-world evidence refers to data collected…

The European Medicines Agency (EMA) has officially declared the gradual discontinuation of exceptional regulatory flexibilities that were put in place during the COVID-19 pandemic. These…

The European Medicines Agency (EMA) recently issued an essay outlining the main points of the Pharmacovigilance Risk Assessment Committee (PRAC) conference, which took place from…

In response to an ongoing review, the European Medicines Agency (EMA) has issued a statement regarding GLP-1 receptor agonists. These medications are commonly used in…

The Committee for Veterinary Medicinal Products (CVMP) recently finished its conference, which focused on enhancing animal health and welfare from July 11 to 13, 2023.…